[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Laboratory Corp of America (LH)

Laboratory Corp of America (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Laboratory Corp: The Diagnostics Momentum That Brought a Guidance Raise Gets Its Second Test

Laboratory Corp of America Holdings (NYSE: LH) reports second quarter 2026 earnings tomorrow morning before the open, with analysts expecting $4.79 per share on revenue of $3.72 billion. The report comes as the clinical laboratory giant trades near 52-week highs following four consecutive quarters of earnings beats, with investors focused on organic volume growth in diagnostics, operating margin expansion, and management's updated outlook for capital allocation. With the stock up over 15% from its 52-week low and Wall Street maintaining overwhelmingly bullish sentiment, the key question is whether LabCorp can sustain its momentum amid evolving reimbursement dynamics and competitive pressures...

Fundamentals

See More
  • Market Capitalization, $K 25,766,860
  • Shares Outstanding, K 82,000
  • Annual Sales, $ 13,952 M
  • Annual Income, $ 876,500 K
  • EBIT $ 1,730 M
  • EBITDA $ 2,411 M
  • 60-Month Beta 0.89
  • Price/Sales 1.77
  • Price/Cash Flow 12.13
  • Price/Book 2.84

Options Overview Details

View History
  • Implied Volatility 33.22% (+1.96%)
  • Historical Volatility 26.85%
  • IV Percentile 98%
  • IV Rank 98.60%
  • IV High 33.46% on 04/13/26
  • IV Low 16.57% on 08/22/25
  • Expected Move (DTE 22) 19.32 (6.29%)
  • Put/Call Vol Ratio 4.88
  • Today's Volume 547
  • Volume Avg (30-Day) 181
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 3,053
  • Open Int (30-Day) 3,907
  • Expected Range 287.83 to 326.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $4.79
  • Number of Estimates 7
  • High Estimate $5.02
  • Low Estimate $4.71
  • Prior Year $4.35
  • Growth Rate Est. (year over year) +10.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
262.11 +17.19%
on 07/14/26
315.77 -2.73%
on 07/28/26
+27.57 (+9.86%)
since 06/29/26
3-Month
248.59 +23.56%
on 05/05/26
315.77 -2.73%
on 07/28/26
+50.01 (+19.45%)
since 04/29/26
52-Week
244.52 +25.61%
on 11/07/25
315.77 -2.73%
on 07/28/26
+45.43 (+17.36%)
since 07/29/25

Most Recent Stories

More News
Laboratory Corp: The Diagnostics Momentum That Brought a Guidance Raise Gets Its Second Test

Barchart Research What to Expect from LH Earnings LH Generated July 29, 2026 Current Price $307.15 EPS Estimate $$4.79 Consensus Rating Strong Buy Average Move 4.18% Laboratory Corp: The Diagnostics Momentum...

LH : 307.15 (-2.25%)
What To Expect From Labcorp’s (LH) Q2 Earnings

What To Expect From Labcorp’s (LH) Q2 Earnings

LH : 307.15 (-2.25%)
Labcorp Launches Marker by Labcorpâ„¢ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing

BURLINGTON, N.C. , July 27, 2026 /PRNewswire/ -- Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of Marker by Labcorp™...

LH : 307.15 (-2.25%)
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

IART : 16.49 (-16.55%)
ANIP : 81.78 (+0.91%)
LH : 307.15 (-2.25%)
Labcorp Declares Quarterly Dividend

BURLINGTON, N.C. , July 9, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board...

LH : 307.15 (-2.25%)
Here's What to Expect From Labcorp Holdings’ Next Earnings Report

Labcorp Holdings will report its second-quarter results by the end of this month, and analysts are anticipating a low-double-digit increase in earnings.

XLV : 166.24 (-0.61%)
$SPX : 7,316.15 (-1.52%)
LH : 307.15 (-2.25%)
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

BURLINGTON, N.C. , June 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc . (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for...

LH : 307.15 (-2.25%)
3 Mid-Cap Stocks Walking a Fine Line

3 Mid-Cap Stocks Walking a Fine Line

TOL : 150.20 (-3.08%)
VLTO : 98.83 (+0.37%)
LH : 307.15 (-2.25%)
3 Reasons LH is Risky and 1 Stock to Buy Instead

3 Reasons LH is Risky and 1 Stock to Buy Instead

LH : 307.15 (-2.25%)
Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks

Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks

LH : 307.15 (-2.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C.

See More

Key Turning Points

3rd Resistance Point 321.23
2nd Resistance Point 318.00
1st Resistance Point 312.57
Last Price 307.15
1st Support Level 303.91
2nd Support Level 300.68
3rd Support Level 295.25

See More

52-Week High 315.77
Last Price 307.15
Fibonacci 61.8% 288.55
Fibonacci 50% 280.15
Fibonacci 38.2% 271.74
52-Week Low 244.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.